Contraceptive Market

Global Contraceptive Market Size, Share And Trend Analysis Report By Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), By Age Group (15–24 Years, 25–34 Years, 35–44 Years, and Above 44 Years), and By End-User (Homecare, Hospitals, and Clinics), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025295 | Category : Pharmaceuticals | Delivery Format: /

The global contraceptive market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is fuelling the global contraceptive market growth during the forecast period includes the increasing number of unplanned pregnancies and their consequences, particularly among teenage women.

Unwanted pregnancies are on the rise, globally. Government bodies of various countries have been taking measures, like promoting the use of contraceptive pills, to reduce the number of unwanted pregnancies, which is another factor that is expected to boost the demand of the market during the forecast period. An increasing number of unwanted pregnancies, given their widespread implications, is also a major factor that is expected to boost market growth. Moreover, the governments of various countries are found doing family planning programs and contraception awareness programs to expand the knowledge about contraceptives and their advantages in preventing unwanted pregnancy is also anticipated to drive the market demand during the forecast period. 

The Contraceptive Market analysis includes some of the key market players such as Bayer Healthcare, Amneal Pharmaceuticals LLC, Teva Pharmaceuticals, Abbvie Inc. (Allergan PLC), Pfizer Inc., and Johnson & Johnson, among others. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Bayer Healthcare, Amneal Pharmaceuticals LLC, Teva Pharmaceuticals, Abbvie Inc. (Allergan PLC), Pfizer Inc., and Johnson & Johnson, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Contraceptive Market by Segment

By Product 

Oral Contraceptive Pills

Injectable Contraceptives

Topical Contraceptives’

By Age Group 

15–24 Years

25–34 Years

35–44 Years

Above 44 Years

By End-User 

Homecare

Hospitals

Clinics

Global Contraceptive Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World